What Is Akkermansia muciniphila? Why This Gut Bacterium Is Getting So Much Attention
There is a part of your gut you probably do not spend much time thinking about: the thin layer of mucus that helps protect the intestinal lining. It is also home to one of the most talked-about bacteria in microbiome science.
Akkermansia muciniphila is a naturally occurring bacterium found in the human gut, especially around the intestinal mucus layer. It can use nutrients from mucin, an important part of that mucus. Researchers are studying how Akkermansia interacts with the gut environment and its possible connections with barrier biology and metabolic health. The benefits of taking it as a supplement are still being investigated.
At Healthy, we stock CODEAGE Akkermansia 500 Ultra for people who are curious about a capsule built around this particular organism. But first, what is so unusual about the place where it lives?
Meet Akkermansia, a bacterium with an unusual home
Picture the inside of the intestine. Food moves through its central space, while a mucus-rich layer helps separate those contents from the cells lining the gut. That protective layer is a normal part of gut health.
Akkermansia muciniphila is particularly well adapted to this neighbourhood. Unlike many familiar gut bacteria, it is known for living close to the mucus.
Its name hints at this special feature. Mucin is the name for a family of proteins with sugars attached that give mucus some of its characteristic properties. Akkermansia has enzymes that allow it to use parts of mucin as food.
This does not mean it simply destroys the gut lining. Mucus is renewed, and scientists are studying how Akkermansia interacts with it under different conditions.
Why scientists are paying attention to that mucus layer
The mucus layer does more than form a physical separation. It is a busy meeting place for intestinal cells, microorganisms and the substances they produce. Because Akkermansia lives so close to this interface, studying it may help explain how those parts communicate.
Laboratory and animal studies are exploring its involvement in mucus regulation and the intestinal barrier. Those observations do not prove that taking an Akkermansia capsule will have the same effects in people.
There is another reason to pay attention. As it breaks down mucin-derived material, Akkermansia can produce compounds that other gut microbes may use. One bacterium's activity can therefore influence its neighbours. It is a reminder that the microbiome works as a community rather than as a collection of isolated 'good' and 'bad' bacteria.
Scientists are also investigating links between Akkermansia, the wider microbial community and metabolic measurements. Observational links do not prove cause and effect.
Importantly, more is not always better. A 2025 scientific review highlighted that mucus breakdown can have different effects depending on factors such as diet and the state of the gut microbial community. That is why the research is exciting, but also why simple promises about Akkermansia would miss the point.
What has actually been studied in people?
Human research has started to move beyond observations, although it is still relatively young. In a 2019 exploratory trial, 40 adults with overweight or obesity and insulin resistance were enrolled, and 32 completed the study. Researchers tested live and pasteurised Akkermansia preparations. They found promising signals in some metabolic measurements, particularly with the pasteurised version, but this was a small study in a specific group.
Two studies published in 2026 help show both the promise and the uncertainty. One randomised trial involved 90 adults and tested pasteurised Akkermansia during a weight-maintenance period following an initial diet phase. Another trial, involving 142 adults with metabolic syndrome, found no significant difference from placebo in its main measure of whole-body insulin sensitivity. It also reported exploratory findings in certain subgroups, which need further study.
These trials are valuable, but exactly what was tested matters. None of these trials studied our finished CODEAGE Akkermansia 500 Ultra formula with strain AH39 and chicory inulin. Their results cannot be treated as evidence that this particular capsule changes weight, blood glucose or cholesterol.
Akkermansia is now being studied in people, but we still have much to learn about the effects of different preparations.
Not every Akkermansia supplement is the same as the one in a study
First, the name Akkermansia muciniphila describes a species. Within a species there can be different strains. CODEAGE identifies the strain in its formula as AH39. A result involving another strain cannot automatically be carried over to AH39.
Second, some research uses live organisms and some uses pasteurised ones. Pasteurisation is a heat treatment, so these are not identical preparations. Neither is automatically better simply because it has been studied, and results with pasteurised Akkermansia should not be used to make promises about a live-organism supplement.
Third, the complete capsule matters. Additional ingredients such as fibre make the CODEAGE formulation worth a closer look.
Why our CODEAGE Akkermansia 500 Ultra includes chicory inulin
At Healthy, we like offering something more specific than a general multi-strain probiotic blend. Our CODEAGE Akkermansia 500 Ultra - Advanced Synbiotic identifies Akkermansia muciniphila AH39 and combines it with a plant-derived prebiotic in one vegetarian capsule.
Each labelled serving provides 500 million AFUs of Akkermansia muciniphila AH39 and 276mg of chicory inulin. The ingredient panel also lists the Akkermansia ingredient separately at 150mg. AFU stands for Active Fluorescent Units. It is a different measurement from milligrams or CFUs, and the declared AFU amount is measured at manufacture, not guaranteed to stay unchanged forever.
Why add inulin? Prebiotic fibres can be used by members of the gut microbial community. Chicory inulin brings that fibre component alongside the specialised Akkermansia ingredient, which is why this is described as a synbiotic. That does not prove inulin directly feeds the AH39 strain. If you would like to see other fibre options, you can also explore our prebiotics range.
The capsule has an enteric coating designed to help protect its contents as they travel through the digestive system. That is a thoughtful formulation feature, not a guarantee that every organism reaches a particular destination alive.
The bottle contains 90 vegetarian capsules, with one capsule per day on the adult label directions, giving approximately three months of use. The formula is vegan, non-GMO, dairy-free, soy-free and gluten-free. It is manufactured in the USA using global ingredients in a cGMP-certified facility. These are useful details to have on hand when choosing an Akkermansia supplement in NZ.
What this means if you're thinking about trying Akkermansia
If newer microbiome ingredients interest you, CODEAGE Akkermansia 500 Ultra offers a named strain with prebiotic fibre. You may appreciate its capsule format if you prefer that to a powder or drink.
Our approach is simple: start with what the product actually contains, not an expectation that it will recreate a research result. You can check the full ingredients, serving directions and precautions before deciding whether it is a good fit for you.
A quick safety note: For adults, the label says to take one capsule daily, or follow advice from a healthcare practitioner. Do not exceed the recommended dose. If you are pregnant or breastfeeding, under 18, have a known medical condition, take medication, are immunocompromised or are seriously unwell, seek appropriate medical advice before using a live microorganism supplement. Check for ingredient sensitivities, keep it away from children and pets, and do not use it if the safety seal is missing or damaged.
This is a food supplement, not a treatment for a medical condition, and it should not be used for weight reduction. If ongoing digestive symptoms have led you here, a healthcare professional can help you understand the cause rather than relying on a microbiome test or a supplement alone.
Common questions about Akkermansia
Why are scientists interested in Akkermansia muciniphila?
Its unusual relationship with the intestinal mucus layer makes it an important bacterium to study. Researchers are exploring how it interacts with gut cells, other microorganisms and substances made in the microbiome. Its possible links with gut-barrier biology and metabolic health are still being investigated.
Does Akkermansia live in the gut's mucus layer?
Yes. Akkermansia muciniphila is closely associated with the mucus-rich environment of the intestine. It can use nutrients derived from mucin, a key component of mucus. That is part of its natural biology and does not automatically mean it damages the intestinal lining.
Is Akkermansia different from Lactobacillus and Bifidobacterium?
Yes. Akkermansia belongs to a different group of bacteria and is especially known for its mucus-associated lifestyle. Lactobacillus and Bifidobacterium are better-known names in probiotic products, but no two bacterial species or strains should be expected to behave in exactly the same way.
Are the benefits of Akkermansia supplements proven in humans?
Human trials have been published, which is encouraging, but the evidence is not complete. Findings depend on the people studied and on the strain and preparation used. Research into one Akkermansia preparation does not establish guaranteed results for every supplement sold under the same species name.
Are live and pasteurised Akkermansia the same thing?
No. Live Akkermansia contains living organisms, while pasteurised Akkermansia has been heat-treated. Researchers have studied both forms, but they are not interchangeable. A result from a trial using pasteurised bacteria cannot automatically be applied to a product containing live organisms.
Can diet affect Akkermansia levels naturally?
Dietary patterns, certain fibres and some polyphenol-containing interventions have been studied for possible effects on Akkermansia abundance. Results vary between people and studies. No particular food or diet can promise a set level of Akkermansia, and a higher number is not automatically a sign of better health.
Is CODEAGE Akkermansia 500 Ultra a weight-loss supplement?
No. Our CODEAGE Akkermansia 500 Ultra label specifically says not to use the product for weight reduction. Although some studies have explored metabolic measurements using other Akkermansia preparations, that research does not establish a weight-loss benefit or indication for this finished formula.
Explore Akkermansia at Healthy
It is easy to see why a bacterium that lives so close to the gut's protective mucus layer has caught scientists' attention. There is plenty left to discover, and we are pleased to offer a targeted option for those who want to learn more about Akkermansia supplements.
With AH39, chicory inulin and a one-capsule-per-day format, CODEAGE Akkermansia 500 Ultra makes the ingredients clear. Visit the product page to review the current details and see whether this is the next supplement you would like to explore.
References
- Ioannou A et al. Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential. Nature Reviews Microbiology, 2025.
- Davey L. Loving mucus with Akkermansia muciniphila. Nature Microbiology, 2024.
- Tingler AM, Engevik MA. Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful? Infection and Immunity, 2025.
- Depommier C et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers. Nature Medicine, 2019.
- Mount S et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance. Nature Medicine, 2026.
- Suenaert P et al. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity and related outcomes. Gut Microbes, 2026.
- Verhoog S et al. Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii. Nutrients, 2019.
- Medsafe. Regulation of Dietary Supplements. New Zealand.